Literature DB >> 2548212

Selective changes in mu opioid receptor properties induced by chronic morphine exposure.

L L Werling1, P N McMahon, B M Cox.   

Abstract

Chronic infusion of morphine to guinea pigs produced selective changes in mu agonist binding properties in cerebrocortical membrane preparations. Employing the mu-selective opioid agonist [D-Ala2,MePhe4,Gly-ol5]enkephalin (DAMGO) in direct binding studies and in competition of labeled antagonist binding, we found that the major changes were a decrease in the number of sites with high affinity for agonist, a small reduction in total receptor number, and a loss in the ability of guanosine 5'-[gamma-thio]triphosphate to regulate binding. A fraction of high-affinity mu receptors appeared to retain their high affinity for agonist and their sensitivity to guanine nucleotide analogue after the induction of morphine tolerance, possibly because the morphine concentrations achieved in brain were insufficient to uncouple all mu receptors from associated guanine nucleotide-binding regulatory proteins. Some membrane preparations were treated with pertussis toxin, which has been shown to functionally uncouple mu opioid receptors from their effector systems. In these preparations, a single agonist-affinity state of the receptor was observed. The apparent dissociation constant for this affinity state in pertussis toxin-treated membranes was similar to the lower-affinity state observed in preparations from morphine-tolerant animals. In contrast to the changes observed at mu opioid binding sites, no significant changes in agonist affinity or binding density were observed for selective delta or kappa agonists, consistent with the development of selective tolerance at mu receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548212      PMCID: PMC297846          DOI: 10.1073/pnas.86.16.6393

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  The effect of N-allylnormorphine upon the development of tolerance to morphine in the albino rat.

Authors:  P D ORAHOVATS; C A WINTER; E G LEHMAN
Journal:  J Pharmacol Exp Ther       Date:  1953-12       Impact factor: 4.030

2.  Intact brain cells: a novel model system for studying opioid receptor binding.

Authors:  N F Rogers; E E el-Fakahany
Journal:  Life Sci       Date:  1985-07-29       Impact factor: 5.037

3.  Pertussis toxin blocks the outward currents evoked by opiate and alpha 2-agonists in locus coeruleus neurons.

Authors:  G K Aghajanian; Y Y Wang
Journal:  Brain Res       Date:  1986-04-23       Impact factor: 3.252

4.  Pertussis toxin blocks depressant effects of opioid, monoaminergic and muscarinic agonists on dorsal-horn network responses in spinal cord-ganglion cultures.

Authors:  S M Crain; B Crain; M H Makman
Journal:  Brain Res       Date:  1987-01-01       Impact factor: 3.252

5.  Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus.

Authors:  C Chavkin; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  Coupling of the thyrotropin-releasing hormone receptor to phospholipase C by a GTP-binding protein distinct from the inhibitory or stimulatory GTP-binding protein.

Authors:  D L Aub; E A Frey; R D Sekura; T E Cote
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

7.  Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.

Authors:  L L Werling; P N McMahon; B M Cox
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

8.  Naloxone prevention of morphine LDR curve flattening associated with high-dose tolerance.

Authors:  R F Mucha; H Kalant
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.

Authors:  P S Puttfarcken; L L Werling; B M Cox
Journal:  Mol Pharmacol       Date:  1988-05       Impact factor: 4.436

10.  Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells.

Authors:  H Kurose; T Katada; T Amano; M Ui
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

View more
  18 in total

1.  No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia.

Authors:  C Stein; M Pflüger; A Yassouridis; J Hoelzl; K Lehrberger; C Welte; A H Hassan
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Tolerance and sensitization to chronic escalating dose heroin following extended withdrawal in Fischer rats: possible role of mu-opioid receptors.

Authors:  Katharine M Seip-Cammack; Brian Reed; Yong Zhang; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2012-07-25       Impact factor: 4.530

Review 3.  Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.

Authors:  Javier Garzón; María Rodríguez-Muñoz; Elena de la Torre-Madrid; Pilar Sánchez-Blázquez
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

4.  Alterations in brain metabolism induced by chronic morphine treatment: NMR studies in rat CNS.

Authors:  Sushil K Sharma; Kiran Yashpal; Marian E Fundytus; Françoise Sauriol; James L Henry; Terence J Coderre
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

5.  Chronic intrathecal morphine treatment does not cause down-regulation of spinal adenosine A1 receptors in rats.

Authors:  P L Tao; C S Wong; M C Lin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

6.  Differential down- and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine.

Authors:  M M Belcheva; J Barg; R J McHale; S Dawn; M T Ho; E Ignatova; C J Coscia
Journal:  Mol Pharmacol       Date:  1993-07       Impact factor: 4.436

7.  Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.

Authors:  L Negri; R Lattanzi; P Melchiorri
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.

Authors:  Irma Onoprishvili; Eric J Simon
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

9.  Morphine actions on supraoptic oxytocin neurones in anaesthetized rats: tolerance after i.c.v. morphine infusion.

Authors:  K M Pumford; G Leng; J A Russell
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

10.  Characterization of acute homologous desensitization of mu-opioid receptor-induced currents in locus coeruleus neurones.

Authors:  P B Osborne; J T Williams
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.